KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Current Assets: 2011-2025

Historic Current Assets for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Sep 2025 value amounting to $593.9 million.

  • Supernus Pharmaceuticals' Current Assets fell 7.20% to $593.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $593.9 million, marking a year-over-year decrease of 7.20%. This contributed to the annual value of $686.1 million for FY2024, which is 39.13% up from last year.
  • As of Q3 2025, Supernus Pharmaceuticals' Current Assets stood at $593.9 million, which was down 19.62% from $738.9 million recorded in Q2 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Current Assets peaked at $883.3 million during Q1 2023, and registered a low of $423.5 million during Q2 2023.
  • Over the past 3 years, Supernus Pharmaceuticals' median Current Assets value was $593.9 million (recorded in 2025), while the average stood at $611.9 million.
  • In the last 5 years, Supernus Pharmaceuticals' Current Assets spiked by 55.38% in 2023 and then slumped by 38.38% in 2024.
  • Quarterly analysis of 5 years shows Supernus Pharmaceuticals' Current Assets stood at $601.6 million in 2021, then rose by 22.04% to $734.2 million in 2022, then tumbled by 32.83% to $493.1 million in 2023, then skyrocketed by 39.13% to $686.1 million in 2024, then fell by 7.20% to $593.9 million in 2025.
  • Its Current Assets was $593.9 million in Q3 2025, compared to $738.9 million in Q2 2025 and $687.6 million in Q1 2025.